MediPal Holdings Corporation
7459
Rang in Aktien
#4259
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Aktienkurs
$20.47
Marktkapitalisierung
$3.73B
Veränderung (1 Tag)
-0.57%
Veränderung (1 Jahr)
23.25%
Land
JP
Handel MediPal Holdings Corporation (7459)
Kategorie
Healthcare
Umsatz von MediPal Holdings Corporation (7459)
Umsatz im Jun 2026 TTM: $25.20B
Laut den aktuellen Finanzberichten von MediPal Holdings Corporation beträgt der derzeitige Umsatz des Unternehmens (TTM) $25.20B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $23.51B ein Rückgang im Vergleich zu dem Umsatz im Jahr 2023, der $25.31B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für MediPal Holdings Corporation von 2005 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $25.20B | 2.87% |
| 2025 | $24.49B | 4.17% |
| 2024 | $23.51B | -7.09% |
| 2023 | $25.31B | -6.37% |
| 2022 | $27.03B | -6.78% |
| 2021 | $28.99B | -4.18% |
| 2020 | $30.26B | 5.55% |
| 2019 | $28.67B | -3.20% |
| 2018 | $29.61B | 7.65% |
| 2017 | $27.51B | 2.21% |
| 2016 | $26.91B | 12.36% |
| 2015 | $23.95B | -16.19% |
| 2014 | $28.58B | -4.19% |
| 2013 | $29.83B | -10.02% |
| 2012 | $33.15B | 3.19% |
| 2011 | $32.13B | 17.91% |
| 2010 | $27.25B | 8.82% |
| 2009 | $25.04B | 10.72% |
| 2008 | $22.61B | 23.12% |
| 2007 | $18.37B | 12.44% |
| 2006 | $16.34B | 4.97% |
| 2005 | $15.56B | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| $410.98B | 1,531.20% |
US
|
|
| - | - |
US
|
|
| $254.25B | 909.11% |
US
|
|
| - | - |
US
|
|
| $7.64B | -69.67% |
AU
|
